...
首页> 外文期刊>Vaccine >Use of a GnRH vaccine, GonaCon (TM), for prevention and treatment of adrenocortical disease (ACD) in domestic ferrets
【24h】

Use of a GnRH vaccine, GonaCon (TM), for prevention and treatment of adrenocortical disease (ACD) in domestic ferrets

机译:GnRH疫苗GonaCon(TM)在预防和治疗家庭雪貂中肾上腺皮质疾病(ACD)中的用途

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Adrenocortical disease (ACD) is a common problem in surgically sterilized, middle-aged to old ferrets (Mustela putorius furo). The adrenal tissues of these ferrets develop hyperplasia, adenomas, or adenocarcinomas, which produce steroid hormones including estradiol, 17-hydroxyprogesterone, and androstenedione. Major clinical signs attributable to overproduction of these hormones are alopecia (hair loss) in both sexes and a swollen vulva in females. Pruritus, muscle atrophy, hind limb weakness, and sexual activity or aggression are also observed in both sexes. Males can develop prostatic cysts, prostatitis, and urethral obstruction. ACD is thought to be linked to continuous and increased LH secretion, due to lack of gonadal hormone feedback in neutered ferrets. This continuous elevated LH acts on adrenal cortex LH receptors, resulting in adrenal hyperplasia or adrenal tumor. This study investigated whether the immunocontraceptive vaccine GonaCon (TM), a GnRH vaccine developed to reduce the fertility of wildlife species and the spread of disease, could prevent or delay onset of ACD and treat alopecia in ferrets with existing ACD. Results showed that GonaCon provided relief from ACD by causing production of antibodies to GnRH, probably suppressing production and/or release of LH. Treatment caused many ACD symptoms to disappear, allowing the ferrets to return to a normal life. The study also found that the probability of developing ACD was significantly reduced in ferrets treated with GonaCon when young (1-3 years old) compared to untreated control animals. GonaCon caused injection site reaction in some animals when administered as an intramuscular injection but caused few side effects when administered subcutaneously. Both intramuscular and subcutaneous vaccination resulted in similar levels of GnRH antibody titers. Subcutaneous vaccination with GonaCon is thus recommended to prevent the onset of ACD and as a possible treatment for ACD-signs in domestic ferrets. Published by Elsevier Ltd.
机译:肾上腺皮质疾病(ACD)是经过手术消毒的中老年至老白鼬(Mustela putorius furo)的普遍问题。这些雪貂的肾上腺组织发生增生,腺瘤或腺癌,它们会产生类固醇激素,包括雌二醇,17-羟基孕酮和雄烯二酮。归因于这些激素过量产生的主要临床体征是两性脱发(女性脱发)和女性外阴肿胀。在男女中也观察到瘙痒,肌肉萎缩,后肢无力以及性活动或攻击性。男性会出现前列腺囊肿,前列腺炎和尿道梗阻。由于在绝育的雪貂中缺乏性腺激素反馈,因此认为ACD与LH的持续分泌增加有关。这种持续升高的LH作用于肾上腺皮质LH受体,导致肾上腺增生或肾上腺肿瘤。这项研究调查了GnRH免疫避孕疫苗GonaCon(TM)是否开发来降低野生动植物物种的繁殖力和疾病传播,是否可以预防或延迟ACD的发作并治疗现有ACD的雪貂脱发。结果表明,GonaCon通过引起针对GnRH的抗体产生,可能抑制了LH的产生和/或释放,从而减轻了ACD的负担。治疗使许多ACD症状消失,使雪貂恢复正常生活。该研究还发现,与未治疗的对照动物相比,年轻(1-3岁)时用GonaCon治疗的雪貂显着降低了产生ACD的可能性。当以肌内注射方式给药时,GonaCon在某些动物中引起注射部位反应,但在皮下给药时几乎没有副作用。肌内和皮下疫苗接种均导致相似水平的GnRH抗体滴度。因此,建议使用GonaCon进行皮下疫苗接种,以预防ACD的发作,并可能作为家养雪貂中ACD体征的治疗方法。由Elsevier Ltd.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号